Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06453954
Other study ID # 325846
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 17, 2023
Est. completion date February 21, 2024

Study information

Verified date June 2024
Source University of Manchester
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to learn about the implementation of NHS England's Saving Babies Lives Care Bundle Version 2 to reduce perinatal mortality. It will explore whether the care bundle is effective at reducing stillbirth rates, neonatal death rates and preterm births in England. It will also explore the lived experiences of women's maternity care and their babies neonatal care, and the views and experiences of healthcare professionals who are involved in delivering the care bundle. The main questions it aims to answer are: - Does the care bundle reduce perinatal mortality rates? - What are women's views and experiences of their maternity and neonatal care? - What are the barriers around delivering the care bundle and how can this be improved? - How do health inequalities affect the care women receive? - How does the workforce culture affect how healthcare professionals use the care bundle? Perinatal mortality rates and other pregnancy outcomes will be obtained from national data sources. Women and healthcare professionals will be asked to complete a survey and we will interview select groups of participants to further explore their experiences. Mortality rates will be compared before and after the implementationof the care bundle where data allows. Data from the surveys will be descriptive. Data from the interviews will be analysed using thematic analysis to determine patterns and recurring ideas in the data.


Description:

In April 2022, NHS England commissioned the University of Manchester to conduct an independent evaluation of the effectiveness of the Saving Babies' Lives Care Bundle Version 2 (SBLCBv2) on reducing perinatal mortality in England. The study was commissioned in two phases. Phase 1 comprises a national (service) evaluation of the impact of the SBLCBv2 on perinatal mortality rates, associated clinical outcomes, and any unintended consequences using routine data derived from national databases. Phase 2 comprises a qualitative evaluation to further understand the impact on maternity services, women and their families. Phase 2 will be conducted in a cohort of maternity units across England using a mixed-methods approach. The views and experiences of women and healthcare professionals towards maternity care in relation to the SBLCBv2 will be sought using surveys and interviews. Additionally, this study will interview organisational leads to assess how resources, leadership and governance may affect implementation in diverse hospital settings.


Recruitment information / eligibility

Status Completed
Enrollment 1773
Est. completion date February 21, 2024
Est. primary completion date January 31, 2024
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Phase 1: All births in England. Phase 2: Inclusion Criteria: - women who have given birth in the last 12 months - women who can understand English - healthcare professionals involved in delivering the care bundle Exclusion Criteria: - women who gave birth more than 12 months ago - women who cannot understand English - women without access to the internet for online survey completion - healthcare professionals not involved in delivering the care bundle

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United Kingdom Manchester Foundation Trust Manchester

Sponsors (1)

Lead Sponsor Collaborator
University of Manchester

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of stillbirths in England A baby born after 24 or more weeks completed gestation and which did not, at any time, breathe or show signs of life Up to 60 months
Secondary Number of babies born preterm A baby born before 37 weeks gestation Up to 60 months
Secondary Number of neonatal deaths in England A live born baby (born at 20+0 weeks gestational age or later, or with a birthweight of 400g or more where an accurate estimate of gestation is not available), who died before 28 completed days after birth Up to 60 months
Secondary Number of babies born small for gestational age (SGA) Birthweight less than the 10th percentile for gestational age Up to 60 months
Secondary Number of women who had a caesarean section Women delivering by emergency or elective caesarean section Up to 60 months
Secondary Number of women who had induction of labour Induced delivieries Up to 60 months
Secondary Number of women who had an instrumental delivery Women who had a forceps or ventouse delivery Up to 60 months
Secondary Number of women who had a spontaneous delivery Spontaneous delivery without forceps or ventouse delivery Up to 60 months
Secondary Number of babies admitted to neonatal care A baby first admitted at the given quarter to any neonatal care unit Up to 84 months
Secondary Number of babies admitted to neonatal care by gestation A baby first admitted at the given quarter to a neonatal care unit by gestation weeks at birth Up to 84 months
Secondary Number of babies admitted to neonatal care by cause of death A baby first admitted at the given quarter to a neonatal care unit by clinical diagnosis Up to 84 months
Secondary Number of babies who died whilst on neonatal care A baby first admitted at any given quarter to a neonatal care unit that died at any point Up to 84 months
See also
  Status Clinical Trial Phase
Completed NCT05017974 - Research on Improving Sleep During Pregnancy N/A
Completed NCT03284515 - Vaccination In Pregnancy Gene Signature: VIP Signature Study
Recruiting NCT05969795 - Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support Phase 1
Recruiting NCT06051201 - Innovation for Small-scale Experiments: ReceptIVFity Test N/A
Recruiting NCT04828382 - Prospective Study of Pregnancy in Women With Cystic Fibrosis
Enrolling by invitation NCT04527926 - STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy N/A
Recruiting NCT04278651 - Early Antenatal Support for Iron Deficiency Anemia Phase 4
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Recruiting NCT06258902 - Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
Completed NCT05487196 - Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia Phase 2
Completed NCT03750968 - Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects Phase 2
Enrolling by invitation NCT06127277 - Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care N/A
Completed NCT05897697 - Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
Recruiting NCT05899101 - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Completed NCT04296396 - Opioid Prescription After Cesarean Trial Phase 3
Not yet recruiting NCT06069869 - Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06069856 - Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Not yet recruiting NCT06079918 - Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania Phase 3